AstraZeneca PLC Forges $400 Million Parkinson's R&D Deal With Takeda Post author:Sam Post published:August 28, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Warning: These Could be the Top 3 Most Overrated Biotech Stocks June 18, 2017 Puma Biotech Receives FDA Advisory Committee Support For Neratinib May 25, 2017 Massachusetts' Exosome Diagnostics Snags $30 Million July 24, 2017